Top

Published in:

Open Access 01-12-2024 | Sulfonamide | Review

Sulfonamides in ophthalmology: adverse reactions

Evidence-based use of sulfa drugs in ophthalmology

Authors: David Daniel, Stephen Bacchi, Robert Casson, Weng Chan

Dear Editor, …

Smith WB, Katelaris CH (2008) ‘Sulfur allergy’ label is misleading. Aust Prescr 31(1):8–10CrossRef

Chow TG, Khan DA (2022) Sulfonamide hypersensitivity. Clin Rev Allerg Immunol 62:400–412. https://doi.org/10.1007/s12016-021-08872-3CrossRef

Mittra RA, Mieler WF (2013) Drug toxicity of the posterior segment. In: Ryan SJ, Sadda SR, Hinton DR, Schachat AP, Sadda SR, Wilkinson CP, Wiedemann P, Schachat AP (eds) Retina, 5th edn. W.B. Saunders, Philadelphia, pp 1532–1554. https://doi.org/10.1016/B978-1-4557-0737-9.00089-8CrossRef

Malagola R, Arrico L, Giannotti R, Pattavina L (2013) Acetazolamide-induced cilio-choroidal effusion after cataract surgery: unusual posterior involvement. Drug Des Dev Ther 7:33–36. https://doi.org/10.2147/DDDT.S38324CrossRef

Shah TJ, Moshirfar M, Hoopes PC (2018) ‘Doctor, i have a sulfa allergy’: clarifying the myths of cross-reactivity. Ophthalmol Therapy 7(2):211–215. https://doi.org/10.1007/s40123-018-0136-8CrossRef

Title: Sulfonamides in ophthalmology: adverse reactions
Evidence-based use of sulfa drugs in ophthalmology
Authors: David Daniel
Stephen Bacchi
Robert Casson
Weng Chan
Publication date: 01-12-2024
Publisher: Springer Netherlands
Keywords: Sulfonamide
Acetazolamide
Nausea
Agranulocytosis
Published in: International Ophthalmology / Issue 1/2024
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-024-03045-5